Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on July 28, 2026

Jul. 28, 2026

Shareholders who lost money in shares of Planet Fitness, Inc. (NYSE: PLNT) Should Contact Wolf Haldenstein Immediately

Indeterminate GlobeNewswire

Jul. 28, 2026

Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Planet Fitness, Inc. (NYSE: PLNT): and Primoris Services Corporation (NYSE: PRIM): Grabar Law Office is Investigating Claims on Your Behalf

Indeterminate GlobeNewswire

Jul. 28, 2026

Gaxos Sharpens Focus to Accelerate Growth Across Revenue-Generating AI and Health and Wellness Platforms

Indeterminate GlobeNewswire

Jul. 28, 2026

Grief goes global on screen as first-of-its-kind festival receives over 500 films from six continents

Indeterminate GlobeNewswire

Jul. 28, 2026

Giada De Laurentiis, Gabby Reece and Walmart's Dee Charlemagne Lead Newtopia Now 2026 Keynotes

Indeterminate GlobeNewswire

Jul. 28, 2026

Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Jul. 28, 2026

Starget Pharma Expands Scientific Advisory Board with Appointment of Two Global Leaders in Radiopharmaceutical Therapy

Indeterminate GlobeNewswire

Jul. 28, 2026

CorVascular Named Exclusive U.S. Importer and Vascular Distributor for ASUS FDA-Cleared Ultrasound Portfolio

Indeterminate GlobeNewswire

Jul. 28, 2026

Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce

Indeterminate GlobeNewswire

Jul. 28, 2026

Slate Medicines Establishes Clinical and Scientific Advisory Boards to Advance Next-Generation Migraine Prevention Therapeutics

Indeterminate GlobeNewswire

Jul. 28, 2026

New Survey: Digestive Side Effects Cause 41% of GLP-1 Users to Suffer in Silence, Self-Adjust, or Consider Quitting

Indeterminate GlobeNewswire

Jul. 28, 2026

Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results

Indeterminate GlobeNewswire

Jul. 28, 2026

Illume Fertility Survey Highlights Hidden Workplace Burden of IVF

Indeterminate GlobeNewswire

Jul. 28, 2026

Claris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments

Indeterminate GlobeNewswire

Jul. 28, 2026

Oak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome

Indeterminate GlobeNewswire

Jul. 28, 2026

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

Indeterminate GlobeNewswire

Jul. 28, 2026

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 28, 2026

YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada

Indeterminate GlobeNewswire

Jul. 28, 2026

Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK

Indeterminate GlobeNewswire

Jul. 28, 2026

Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

Indeterminate GlobeNewswire